SEC Comment Letter for PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981) (CNSY) — Jan 10, 2017
PLUS THERAPEUTICS, INC. (CNSY) (CIK 0001095981)
Date: Jan. 10, 2017 · CIK: 0001095981 · Accession: 0000000000-17-001005
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-215365
Letter
Mail Stop 3030 January 10, 2017 Via E -mail Marc H. Hedrick, MD Chief Executive Officer Cytori Therapeutics, Inc. 3020 Callan Road San Diego, CA 92121
Re: Cytori Therapeutics, Inc. Registration Statement on Form S-1 Filed December 30, 2016 File No. 333-215365
Dear Dr. Hedrick :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Heather Percival at (202) 551 -3498 with any questions.
Sincerely,
/s/ Heather Percival for
Show Raw Text
Mail Stop 3030 January 10, 2017 Via E -mail Marc H. Hedrick, MD Chief Executive Officer Cytori Therapeutics, Inc. 3020 Callan Road San Diego, CA 92121 Re: Cytori Therapeutics, Inc. Registration Statement on Form S-1 Filed December 30, 2016 File No. 333-215365 Dear Dr. Hedrick : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Heather Percival at (202) 551 -3498 with any questions. Sincerely, /s/ Heather Percival for Amanda Ravitz Assistant Director Office of Electronics and Machinery cc: Cheston J. Larson, Esq. Latham & Watkins LLP